๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The primary objective of the study was to assess the effect of gefitinib on...
Status
Unknown
Location
Sun Yat-Sen Univercity Cancer Center
Start Date
2020-05-26
Trial ID
NCT04390984
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of convers...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-03-17
Trial ID
NCT05099848
Treatments Being Tested
This was a multicenter, randomized, double-blind, phase III trial. This cli...
Status
Completed
Location
Jiangsu hengrui medicine CO. LTD
Start Date
2014-03-26
Trial ID
NCT02329860
This prospective real-world study aims to evaluate the effectiveness and sa...
Status
Recruiting
Location
Air Force Military Medical University
Start Date
2025-12-10
Trial ID
NCT07569679
Treatments Being Tested
Apatinib plus XELOX regime as Neoadjuvant Therapy in Locally Advanced Gastr...
Status
Unknown
Location
ZhongShan hospital FuDan university
Start Date
2017-02-01
Trial ID
NCT03229096
Treatments Being Tested
This is an Open Label, Prospective, Multicentre, Non-interventional Study o...
Status
Unknown
Location
Department of Oncology and Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Start Date
2015-09
Trial ID
NCT02668380
Apatinib mesylate is a multitarget receptor tyrosine kinase inhibitor. This...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-08-20
Trial ID
NCT04012827
Treatments Being Tested
This study is a prospective, open-label, phase II clinical trial that aims ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-01
Trial ID
NCT06385873
Treatments Being Tested
The study is to evaluate the efficacy and safety of Apatinib for later trea...
Status
Unknown
Location
Guilin Medical University
Start Date
2017-01-01
Trial ID
NCT03130270
Treatments Being Tested
Triple-negative breast cancer (TNBC) is a special type of breast cancer, en...
Status
Completed
Location
Guangdong general hospital
Start Date
2018-08-01
Trial ID
NCT03243838
Treatments Being Tested